Apoptotic colitis secondary to Brentuximab Vedotin: an immune mediated adverse event responsive to steroid treatment.

Click to increase image sizeClick to decrease image size Disclosure statementThe authors have no conflict of interest to declare, including specific financial interests, relationships and affiliations relevant to the subject matter or materials discussed in the manuscript.Additional informationFundingThis study was partially supported by Italian Ministry of Health – Ricerca Corrente Annual Program 2024. This case report has received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.